ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 24 May 2021
Last Applicant/ Owned by
2855 Gazelle Court
Carlsbad
CA
92010
Serial Number
87661529 filed on 26th Oct 2017
Registration Number
N/A
Correspondent Address
Anne H. Peck
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ZORSANVI
Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical pre Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin
Mark Details
Serial Number
No 87661529
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 097721-20084
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th May 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 24th May 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 15th Oct 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Oct 2020 | EXTENSION 5 GRANTED |
| 14th Oct 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 07th Oct 2020 | EXTENSION 5 FILED |
| 07th Oct 2020 | TEAS EXTENSION RECEIVED |
| 14th Apr 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Apr 2020 | EXTENSION 4 GRANTED |
| 10th Apr 2020 | EXTENSION 4 FILED |